Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China
· Delayed Price · Currency is CNY 19.90
+0.19 (0.96%)
Apr 29, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 7.91 billion as of April 29, 2026. Its market cap has decreased by -19.29% in one year.
Market Cap
7.91B
Enterprise Value
5.98B
Revenue
1.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
19.90
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 7.91B, a decrease of -76.82%. That is a compound annual growth rate of -27.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 7.91B | -0.60% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 7.69B |
| Jiangsu Aidea Pharmaceutical Group | 7.44B |
| Chengdu Kanghua Biological Products | 7.43B |
| Suzhou Fengbei Biotech Stock | 7.19B |
| Daan Gene | 8.11B |
| GemPharmatech | 8.17B |
| Anhui Huaheng Biotechnology | 6.94B |
| Zhejiang Ausun Pharmaceutical | 8.47B |